民兴生物 (870227.OC)

+ 收藏

现金流量表(民兴生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
关 闭
完整财报对比
2020年中报2019年年报2019年中报2018年年报2018年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 35,641,199.4088,900,353.2754,249,221.6690,677,653.8591,759,749.36
 收到的税费返还(元) -1,833,672.293,159,941.59--
 收到其他与经营活动有关的现金(元) 26,509,440.665,492,672.012,126,671.993,714,759.5411,345,119.90
 经营活动现金流入小计(元) 62,150,640.0696,226,697.5759,535,835.2494,392,413.39103,104,869.26
 购买商品、接受劳务支付的现金(元) 23,597,160.7565,289,673.0639,452,101.87100,751,121.2168,713,365.61
 支付给职工以及为职工支付的现金(元) 4,487,720.2815,375,654.799,132,781.7814,097,433.867,129,045.00
 支付的各项税费(元) 4,702,337.765,451,947.124,787,353.662,920,020.972,381,745.27
 支付其他与经营活动有关的现金(元) 17,719,766.335,442,287.393,507,431.738,984,341.9225,375,680.68
 经营活动现金流出小计(元) 50,506,985.1291,559,562.3656,879,669.04126,752,917.96103,599,836.56
 经营活动产生的现金流量净额(元) 11,643,654.944,667,135.212,656,166.20-32,360,504.57-494,967.30
二、投资活动产生的现金流量
 收回投资收到的现金(元) ---42,000,000.00-
 取得投资收益收到的现金(元) ---4,767,500.004,767,500.00
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -761,615.89---
 收到其他与投资活动有关的现金(元) -13,400,000.00-13,814,721.07-
 投资活动现金流入小计(元) -14,161,615.89-60,582,221.074,767,500.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 31,669,624.949,386,109.376,738,637.3414,312,272.8710,584,226.01
 投资支付的现金(元) ---750,000.00-
 取得子公司及其他营业单位支付的现金净额(元) ----750,000.00
 支付其他与投资活动有关的现金(元) -18,000,000.00-18,814,721.07-
 投资活动现金流出小计(元) 31,669,624.9427,386,109.376,738,637.3433,876,993.9411,334,226.01
 投资活动产生的现金流量净额(元) -31,669,624.94-13,224,493.48-6,738,637.3426,705,227.13-6,566,726.01
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 28,000,000.0039,000,000.0015,000,000.0018,000,000.0030,000,000.00
 收到其他与筹资活动有关的现金(元) -51,320,000.004,888,535.0051,200,000.00-
 筹资活动现金流入小计(元) 28,000,000.0090,320,000.0019,888,535.0069,200,000.0030,000,000.00
 偿还债务支付的现金(元) 19,095,372.3823,000,000.00-59,000,000.0038,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 1,781,616.002,744,179.411,279,377.513,063,869.721,242,971.49
 支付其他与筹资活动有关的现金(元) -44,285,087.2815,323,261.8331,417,000.00-
 筹资活动现金流出小计(元) 20,876,988.3870,029,266.6916,602,639.3493,480,869.7239,242,971.49
 筹资活动产生的现金流量净额(元) 7,123,011.6220,290,733.313,285,895.66-24,280,869.72-9,242,971.49
四、汇率变动对现金及现金等价物的影响
五、现金及现金等价物净增加额
 加:期初现金及现金等价物余额(元) 13,112,856.001,379,480.961,379,480.9631,315,628.1231,359,612.72
 期末现金及现金等价物余额(元) 209,897.6213,112,856.00582,905.481,379,480.9615,054,947.92
补充资料:
 净利润(元) 10,445,147.378,920,694.823,424,135.1021,447,213.927,825,856.25
 资产减值准备(元) 342,407.67-453,343.91-136,939.44-84,811.32-511,115.88
 固定资产和投资性房地产折旧(元) 2,132,668.004,122,296.522,060,294.573,486,546.351,715,335.48
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 2,132,668.004,122,296.522,060,294.573,486,546.351,715,335.48
 无形资产摊销(元) 238,112.79359,771.89121,659.10359,771.84145,990.92
 处置固定资产、无形资产和其他长期资产的损失(元) --6,230.34---
 公允价值变动损失(元) --64,445.48--
 财务费用(元) 1,781,616.003,453,598.12-4,881,940.581,092,971.49
 投资损失(元) ----24,821,984.20-4,767,500.00
 递延所得税(元) 3,812.6280,502.94-30,380.72127,778.97
  其中:递延所得税资产减少(元) 3,812.6280,502.94-30,380.72127,778.97
 存货的减少(元) -9,331,618.44-16,614,381.74-9,657,528.42-39,796,537.81-22,992,307.56
 经营性应收项目的减少(元) -12,106,503.8511,910,814.954,222,625.55-8,778,924.69-32,100,556.08
 经营性应付项目的增加(元) 18,138,012.78-7,106,588.04155,238.2210,915,900.0448,968,579.11
 其他(元) --2,402,236.04--
 现金的期末余额(元) 209,897.6213,112,856.00582,905.481,379,480.9615,054,947.92
 减:现金的期初余额(元) 13,112,856.001,379,480.961,379,480.9631,315,628.1231,359,612.72
 现金及现金等价物的净增加额(元) -12,902,958.3811,733,375.04-796,575.48-29,936,147.16-16,304,664.80
公告日期 2020-08-242020-04-292019-08-222019-04-232018-08-21
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院